Prostatic Neoplasms: all 6,484 studies
Page 2 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Development of an AI-Agent for Urological Disease Diagnosis and TreatmentRecruitingNCT07721935
- A Study in Patients With Metastatic Castration-Resistant Prostate CancerRecruitingNCT07719361Phase 1
- Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate CancerNot yet recruitingNCT07717099Phase 2
- Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical ProstatectomyRecruitingNCT07711314Phase 2
- A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate CancerRecruitingNCT07711184Phase 1
- Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)RecruitingNCT07711002Phase 3
- Transperineal Versus Transrectal Cognitive Fusion Prostate BiopsyRecruitingNCT07710807Not applicable
- Radioactive Counts From PSMA PET/CT-Targeted Biopsy Specimens for Real-time Diagnosis of Prostate Cancer: A Prospective StudyNot yet recruitingNCT07709403
- Targeted Biopsy, Rapid Pathology, and Immediate Surgery in USTC High-Risk Prostate Cancer: A Prospective Multicenter StudyNot yet recruitingNCT07709338Not applicable
- Large Language Model-Assisted cTNM Annotation From Chinese PSMA PET/CT ReportsRecruitingNCT07707232
- FAPI PET Imaging - An Exploratory StudyNot yet recruitingNCT07705074Phase 1/2
- Pilot Feasibility Study of a Dyadic Culinary Nutrition InterventionNot yet recruitingNCT07702864Not applicable
- Prospective Study of Ultrahypofractionated Proton Beam Therapy for Localized Prostate CancerRecruitingNCT07699705Not applicable
- Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO TrialRecruitingNCT07698535Phase 2
- MRI-DTI Assessment of Urethral Internal Sphincter Ring and Prostate Base MorphologyRecruitingNCT07694752
- Evaluation of Pelvic Floor Function and Psychosocial Sequelae Following Radical Prostatectomy for Prostate CancerEnrolling by invitationNCT07693647
- PSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate CancerRecruitingNCT07691697
- A Study of a New PET Scanner in People With CancerRecruitingNCT07690917
- Social, Structural, and Lifestyle Drivers of Prostate Cancer DisparitiesRecruitingNCT07690579
- Infrared Fluorescence Staining Versus Frozen Section for Prostate Cancer SurgeryNot yet recruitingNCT07690462
- Development and Validation of a Non-Invasive AI Diagnostic Model for Prostate Cancer Using Multiparametric MRI and PSMA PET/CTEnrolling by invitationNCT07690306
- A Clinical Study of [68Ga]Ga-ELI421 Injection PET Imaging in Patients With Prostate CancerRecruitingNCT07689656Phase 1/2
- IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation TherapyRecruitingNCT07686380Phase 2
- Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic Prostate CancerRecruitingNCT07686016
- Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer TreatmentNot yet recruitingNCT07685249Not applicable
- Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate CancerNot yet recruitingNCT07682649Phase 1
- Predictors of BCR After RARP for Localized Prostate Cancer: A Retrospective AnalysisNot yet recruitingNCT07682584
- Effects of Combined Training in Prostate Cancer PatientsNot yet recruitingNCT07680920Not applicable
- Total en Bloc Urethra Preservation at Robot-assisted Prostatectomy IDEAL Stage 2aRecruitingNCT07678489Not applicable
- 177Lu-PSMA-617 Combined With Darolutamide in Neoadjuvant Treatment of High-risk Localized Prostate Cancer: a Prospective, Single-arm, Multi-center Clinical TrialNot yet recruitingNCT07677566Phase 4
- Response With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed Radiotherapy DeliveryNot yet recruitingNCT07674771Early Phase 1
- PROLONG (PRostateOLaparibONcombinationGcc) StudyNot yet recruitingNCT07674121
- A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or DarolutamideRecruitingNCT07672119
- COQ10 and Vitamin E for Off-Target Radiation ToxicityNot yet recruitingNCT07668284Phase 1/2
- Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate CancerRecruitingNCT07667400Phase 1/2
- A Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid TumorsRecruitingNCT07661641Phase 1
- Effects of Direct Artery Injection on Prostate Cancer Drug Delivery and Tumor Uptake: Imaging-Based Prediction of Treatment EffectivenessNot yet recruitingNCT07656337Not applicable
- Sexual Health Communication Skills Training Intervention for Patients With Prostate CancerNot yet recruitingNCT07655557Not applicable
- Water Vapor Ablation for Grade Group 3 Prostate CancerNot yet recruitingNCT07652164Not applicable
- WATER IV PCa (AS Sub-study)Not yet recruitingNCT07650448Not applicable
- Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE TrialRecruitingNCT07650240Phase 2
- This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer.RecruitingNCT07649122Phase 3
- Clinical Data Collection of Patients Treated With High Intensity Focused Ultrasound (HIFU) by the Focal One for Their Prostate Cancer.RecruitingNCT07645872
- Targeted Early Detection Program in Men at High Genetic Risk for Prostate CancerRecruitingNCT07645391
- Nudging Preventive Screening Via Message Framing and BundlingNot yet recruitingNCT07644910Not applicable
- Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory MetastasesNot yet recruitingNCT07644754Not applicable
- MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate CancerRecruitingNCT07644598Phase 2
- Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate CancerRecruitingNCT07641049Phase 1
- 68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid TumorsNot yet recruitingNCT07639801Not applicable
- Sacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior ChemotherapyNot yet recruitingNCT07639086Phase 2
- QLF4113 in Participants With Metastatic Prostate CancerNot yet recruitingNCT07636707Phase 1
- A Phase 2 Trial of 61Cu-NU101 PET/CT Compared Against Current Standard-of-care 18F-piflufolastat (Pylarify®) PET/CT.Not yet recruitingNCT07635524Phase 2
- A Study of Lower Dose Radiation Therapy for People With Prostate CancerRecruitingNCT07635238Phase 2
- MR-guided Single-fraction SBRT for Nodal Oligorecurrent Prostate Cancer (PINPOINT)Not yet recruitingNCT07635108Not applicable
- QLC5508 in Participants With Metastatic Prostate CancerNot yet recruitingNCT07632690Phase 3
- Perspectives About Online InformationNot yet recruitingNCT07631858Not applicable
- Electric Cardiometry-Guided Standard Versus Restricted Fluid Therapy In Robotic ProstaectomyRecruitingNCT07626151Not applicable
- CUIMC Focal Therapy RegistryRecruitingNCT07623941
- A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.Not yet recruitingNCT07623642Phase 2
- Early Diagnosis of PROstate CANcer for Black MenNot yet recruitingNCT07620717Not applicable
- Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored StudyEnrolling by invitationNCT07620574Phase 3
- Expanding Genetic Access for Prostate Cancer SurvivorsNot yet recruitingNCT07618520Not applicable
- Prostate Androgen Response Investigation Using a Stratification BIOmarker; Predicting Prostate Cancer Downstaging by Neoadjuvant Darolutamide With PCAI ImmunoScoreRecruitingNCT07617272Phase 2
- Investigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.RecruitingNCT07615101Phase 3
- Multimodal Imaging and Digital Pathology for Prostate Cancer PredictionRecruitingNCT07614256
- AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)RecruitingNCT07611110Phase 3
- A Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) CancerNot yet recruitingNCT07610083
- First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic CancerRecruitingNCT07608848Early Phase 1
- Effects of Rectal Indomethacin Suppository on Postoperative CRBD in Patients Undergoing LRPRecruitingNCT07607990Not applicable
- Frailty in Older Adults With Prostate Cancer: a Prospective Cohort StudyRecruitingNCT07605936
- A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in Prostate CancerRecruitingNCT07600554Phase 1
- Comparative Analysis of Immunological Responses to Vitamin D Replacement Therapy in Black and West African Men Diagnosed With Prostate Cancer: Elucidating Differential Effects on Immune Function Between Patients With Localized Disease and Those With Metastatic ProgressionNot yet recruitingNCT07598032Phase 3
- Comparing Acupuncture vs. Sham Acupuncture for the Management of Hot Flashes in Prostate Cancer Patients Receiving Hormone TherapyRecruitingNCT07594002Not applicable
- Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate CancerNot yet recruitingNCT07593079Phase 2
- A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor TherapyNot yet recruitingNCT07592910Phase 2
- Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson HospitalRecruitingNCT07591701Not applicable
- Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate CancerNot yet recruitingNCT07591467Phase 3
- Weekly Online CT or MR Adaptive Definitive SBRT for Regionally Metastatic Prostate CancerNot yet recruitingNCT07591051Not applicable
- Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate CancerRecruitingNCT07590934Phase 1/2
- Impact of Body Composition on Dosimetry of 177Lu-PSMA Radioligand TherapyNot yet recruitingNCT07587814Not applicable
- YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate CancerEnrolling by invitationNCT07583160Phase 1
- A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate CancerRecruitingNCT07581184Phase 1
- Quality and Safety of Real-Time Brachytherapy Treatments: Clinical Implementation of a Multipoint Scintillation Detector for Treatment MonitoringNot yet recruitingNCT07580651Not applicable
- Bilateral Versus Unilateral Lymph Node Dissection in High-Risk Prostate Cancer (BALANCE)RecruitingNCT07580196Not applicable
- Radiation Treatment of the Prostate That is Specially Adjusted for Each PersonRecruitingNCT07578519Phase 2
- TENS During Transperineal Prostate BiopsyRecruitingNCT07578324Not applicable
- Pain Comparison: Transrectal vs. Transperineal Prostate BiopsyNot yet recruitingNCT07577895
- Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical ProstatectomyRecruitingNCT07576335Phase 2
- Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active SurveillanceNot yet recruitingNCT07574541Phase 2
- Whole Versus Partial Gland Boost During Prostate SBRTNot yet recruitingNCT07574489Phase 2/3
- Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer.RecruitingNCT07572760Not applicable
- A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate CancerRecruitingNCT07570979Phase 1
- Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceRecruitingNCT07569926Phase 4
- Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer EvaluationNot yet recruitingNCT07568756Phase 2
- Comparing PSMA PET/CT and MRI-RSI for Finding and Outlining Tumors Inside the Prostate in Men With Newly Diagnosed Prostate CancerRecruitingNCT07568613Not applicable
- A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT)RecruitingNCT07568236Phase 2
- A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate CancerRecruitingNCT07567846Phase 1/2
- A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPCRecruitingNCT07567521Phase 1/2
- Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)RecruitingNCT07567027Not applicable
- dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical ProstatectomyNot yet recruitingNCT07564102Phase 1/2